Sunrest Lifescience Reports H1 FY27 Financial Results
Sunrest Lifescience Ltd · Outcome · 15 Nov 2026, 12:28 am
Sunrest Lifescience Reports H1 FY27 Financial Results Sunrest Lifescience approved its unaudited standalone and consolidated financial results for the half year ended 30th Sep'26. On a consolidated basis, total income stood at ₹3,188.54 lakhs compared to ₹3,401.09 lakhs in H1 FY26. Consolidated net profit for the period dropped to ₹56.93 lakhs from ₹73.36 lakhs YoY, with basic and diluted EPS at ₹2.65 versus ₹0.17 YoY. On a standalone basis, revenue from operations rose 38.65% YoY to ₹1,950.78 lakhs, while net profit declined to ₹18.17 lakhs compared to ₹38.56 lakhs in H1 FY26.
Original exchange filing (PDF)
More announcements from Sunrest Lifescience Ltd
- SUNREST LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve Unaudited Standalone and Consolidated financial results for the Half Year ended September 30, 2026 and other business matters · 14 Nov 2026
- Sunrest Lifescience Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter ended on 30th September, 2026 · 20 Oct 2026
- SDD Compliance Certificate for the Quarter ended on 30th September, 2026 · 09 Oct 2026
- Sunrest Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026 in relation to Dissolving the Right Issue due to non receipt of minimum subscription and other other matters · 11 Sept 2026
- Sunrest Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 07, 2026. Further, the company has informed the Exchange regarding voting results. · 07 Sept 2026
- Sunrest Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 07, 2026 · 07 Sept 2026
- Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on September 02, 2026, has decided to extend the issue of equity shares on rights basis in the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Issue Price is Rs. 35 per share. · 02 Sept 2026
